Menopause is an important life event that has not yet been well characterized among women with severe mental illness. Our goal was to evaluate menopause-related quality of life among severely mentally ill women.
Method:
We conducted a cross-sectional assessment of perimenopausal and postmenopausal women, ages 45–55, diagnosed with schizophrenia/schizoaffective disorder, bipolar disorder, or major depression, who were receiving inpatient or outpatient psychiatric care. Women were compared regarding menopausal symptoms and quality of life using the Menopause Specific Quality of Life Scale (MENQOL).
Results:
Women with severe mental illnesses who were peri- and post-menopausal experienced considerable vasomotor, physical, sexual, and psychosocial symptoms related to menopause. On seven of 29 MENQOL items, women with major depression reported problems significantly more often than women with other serious mental illnesses.
Conclusions:
This preliminary study indicates that psychiatrists and other physicians should consider the frequency and overlap of menopausal and psychiatric symptoms among women with serious mental illness in this age group.
HilditchJRLewisJPeterAvan MarisBRossAFranssenEGuyattGHNortonPGDunnE. A menopause-specific quality of life questionnaire: Development and psychometric properties. Maturitas1996; 24: 161–175.
2.
BrzyskiRGMedranoMAHyatt-SantosJMRossJS. Quality of life in low-income menopausal women attending primary care clinics. Fertility and Sterility2001; 76: 44–50.
3.
ConboyLDomarAO'ConnellE. Women at mid-life: Symptoms, attitudes and choices, an Internet based survey. Maturitas2001; 38: 129–136.
HilditchJRLewisJRossAHPeterAvan MarisBFranssenECharlesJNortonPDunnEV. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17B combined with an oral progestin on quality of life in postmenopausal women. Maturitas1996; 24: 177–184.
6.
SajatovicMRosenthalMBPlaxMSMeyerMLBinghamCR. Mental Illness and menopause: A patient and family perspective. Journal of Gender Specific Medicine2003; 6: 31–34.
7.
KhineKLuffJARubinowDRSchmidtPJ. The perimenopause and mood disorders. Primary Psychiatry2003; 10: 44–47.
8.
HarlowBLWiseLAOttoMWSoaresCNCohenLS. Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause. Archives of General Psychiatry2003; 60: 29–36.
9.
GoldEBSternfeldBKelseyJLBrownCMoutonCReameNSalamoneLStellatoR. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. American Journal of Epidemiology2000; 152: 463–473.
10.
FreedmanMA. Quality of life and menopause: The role of estrogen. Journal of Women's Health2002; 11: 703–718.
11.
Ishimaru-TsengTV. Evaluation of late onset bipolar illness during menopause. Hawaii Medical Journal2000; 59: 51–53.
12.
ShortM. Menopause, mood and management. Climacteric2003; 6(Suppl 2): 33–36.
13.
JoffeHSoaresCNCohenLS. Assessment and treatment of hot flashes and menopausal mood disturbance. Psychiatric Clinics of North America2003; 26: 563–580.
14.
GregorianRSGoldenKABahceAGoodmanCKwongWJKhanZM. Antidepressant-induced sexual dysfunction. Annals of Pharmacotherapy2002; 36: 1577–1589.
15.
LoprinziCLSloanJAPerezEAQuellaSKStellaPJMailliardJAHalyardMYPruthiSNovotnyPJRummansTA. Phase III evaluation of fluoxetine for treatment of hot flashes. Journal of Clinical Oncology2002; 20: 1578–1583.
16.
BartonDLLoprinziCLNovotnyPShanafeltTSloanJWahner-RoedlerDRummansTAChristensenBDakhillSRMartinLS. Pilot evaluation of citalopram for the relief of hot flashes. Journal Support Oncology2003; 1: 47–51.
17.
SoaresCNPoitrasJRProutyJ. Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause. Drugs Aging2003; 20: 85–100.
18.
RobinsonGE. Psychotic and mood disorders associated with the perimenopausal period. CNS Drugs2001; 15: 175–184.
19.
BleharMCDePauloJRJrGershonESReichTSimpsonSGNurnbergerJIJr. Women with bipolar disorder: Findings from the NIMH Genetic Initiative sample. Psychopharmacology Bulletin1998; 34: 239–243.
20.
FreemanMPSmithKWFreemanSAMcElroySLKmetzGFWrightRKeckPE. The impact of reproductive events on the course of bipolar disorder in women. Journal of Clinical Psychiatry2002; 63: 284–287.
21.
LindamerLALohrJBHarrisJMcAdamsLAJesteDV. Gender-related clinical differences in older patients with schizophrenia. Journal of Clinical Psychiatry1999; 60: 61–67.
22.
SajatovicMFriedmanSHSchuermeyerINHaysRWIgnacioRVBlowFC. Mental illness and menopause: Subjective experience among women with bipolar disorder, schizophrenia, and major depression. American Psychiatric Association Institute on Psychiatric Services, poster presentation, Boston, October 2003
23.
WatkinsETeasdaleJD. Adaptive and maladaptive self-focus in depression. Journal of Affective Disorders2004; 82: 1–8.
24.
AmadorXFStraussDHYaleSAGormanJM. Awareness of illness in schizophrenia. Schizophrenia Bulletin1991; 17: 113–132.
25.
FranckNFarrerCGeorgieffNMarie-CardineMDaleryJd'AmatoTJeannerodM. Defective recognition of one's own actions in patients with schizophrenia. American Journal of Psychiatry2001; 158: 454–459.
26.
DennersteinLLehertPGuthrieJ. The effects of the menopausal transition and biopsychosocial factors on well-being. Archives of Women's Mental Health2002; 5: 15–22.
27.
LewisCEGroffJYHermanCJMcKeownREWilcoxLS. Overview of women's decision making regarding elective hysterectomy, oophorectomy, and hormone replacement therapy. Journal of Women's Health and Gender Based Medicine2000; 9(Suppl 12): S5–14.
